Back to Journals » Biologics: Targets and Therapy » Volume 1 » Issue 1
Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,742 | Dovepress* | 5,742+ | 1,732 | 7,474 | |
Totals | 5,742 | 1,732 | 7,474 | ||
*Since 15 August 2007 +Since July 2016 |
View citations on Google Scholar